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MorphogenesisTissue development/remodeling requiresmodulations in both cellular architecture and phenotype. Aberration in
these processes leads to tumorigenesis. During the pregnancy/lactation cycle the mammary epithelial cells
undergo complex morphological and phenotypic programs resulting in the acquisition of apical/basal (A/B)
polarization and cellular maturation necessary for proper lactation. Still the hormonal regulations and cellular
mechanisms controlling these events are not entirely elucidated. Here we show that prolactin (PRL)/Jak2 path-
way in mammary epithelial cells uniquely signals to establish A/B polarity as determined by the apical localiza-
tion of the tight junction protein zona occludens 1 (ZO-1) and the basal/lateral localization of E-cadherin, and the
apical trafﬁcking of lipid droplets. As well, our results indicate that this pathway regulates mammary stem cell
hierarchy by inducing the differentiation of luminal progenitor (EpCAMhi/CD49fhi) cells to mature luminal
(EpCAMhi/CD49flow) cells. Moreover, our data indicate that PRL/Jak2 coordinates both of these cellular events
through limiting the mitogen activated protein kinase (Erk1/2) pathway. Together our ﬁndings deﬁne a novel
unifying mechanism coupling mammary epithelial cell A/B polarization and terminal differentiation.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The mammary tissue undergoes extensive morphological and phe-
notypic alterations during the pregnancy/lactation cycle forming a com-
plex network of alveolar structures (Rosen et al., 1994; Macias and
Hinck, 2012). This cellular architecture exhibits well deﬁned A/B polar-
ization established by the adherence and tight junction protein com-
plexes. This polarized epithelial sheet with tight junction barrier
consists of mature luminal epithelial cells functionally capable of syn-
thesis and directional secretion of milk into the lumen of themammary
gland during lactation (Anderson et al., 2007).
While our understanding of the phenotypic differentiation of the
mammary epithelial cells is still limited, however, signature molecules
for various stem/progenitor cell populations have been described
recently (Visvader and Stingl, 2014). Adult mammary glands maintain
a population of stem cells which are capable of generating epithelial
progenitor cells giving rise to terminally differentiated cells. Current
knowledge indicates the complex nature of the mammary stem cell
(MaSC) hierarchy (Fu et al., 2014; Shehata et al., 2012). Based on theentre Research Institute Cancer
2.6232 Montreal, QC, H4A 3J1
. This is an open access article underexpression pattern of cell surface markers EpCAM and CD49f, a dif-
ferentiation model of MaSC was proposed: EpCAMlow/CD49fhi
(bipotent progenitors)-EpCAMhi/CD49fhi (luminal progenitors)-
EpCAMhi/CD49flow (mature luminal cells) (Fu et al., 2014; Shehata
et al., 2012). The hormonal regulations and cellular mechanisms con-
trolling these morphogenic/phenotypic events are not fully determined.
The hormone prolactin (PRL) is known to be indispensable in regu-
lating the development of the mammary gland and promoting the
terminal differentiation of mammary epithelial cells. PRL is known to
mediate these effects through activation of the Jak2/Stat5 pathway. In-
deed, genetically engineered knockout mice lacking either PRL, the
PRL receptor, Jak2 or Stat5 showed limitedmammary alveolar develop-
ment and loss of lactation capacity, implicating a potential role for PRL
in mammary alveolar development (Horseman et al., 1997; Ormandy
et al., 1997; Wagner et al., 2004; Liu et al., 1997). Furthermore, we
have previously shown that PRL signaling through Jak2 to induce re-
epithelialization of mesenchymal breast cancer cells by suppressing
the process of EMT further pointing to a potential role for PRL in regulat-
ing mammary epithelial morphogenesis/polarity (Nouhi et al., 2006).
Here we set to explore the possible role of PRL as a regulator of A/B
polarity establishment and cell fate determination of mammary epithe-
lial cells. Using 3-dimensional (3D) cellular culture systems of mam-
mary epithelial cells we show that PRL speciﬁcally is a key factor in
inducing A/B cell polarization and generation of mature luminal cells.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ability of this signaling cascade to limit the activity of the Erk1/2 path-
way. Together our results describe novel functions for PRL, in addition
to its well-recognized lactogenic role, as an A/B polarity inducer and a
cell fate determinant factor.
2. Methods
2.1. Antibodies, plasmids and other reagents
Antibodies and reagents are listed in supplemental table 1. Small hair-
pin shRNAs in the pLKO.1 lentiviral vector against mouse Jak2 were ob-
tained from The RNAi Consortium (TRC-Mm1.0) lentiviral shRNA library
(Open Biosystems, GE Healthcare). Mature antisense shRNA and their ef-
ﬁcacy in Jak2 suppressionwere listed in supplemental table 2. The scram-
ble shRNA in pLKO.1 vector was obtained from Addgene (Addgene
plasmid #1864). Human Jak2 cDNA in pCIneo vector was a generous
gift from Dr. Olli Silvennoinen (University of Tampere Finland). Other re-
agents were used as described.
2.2. Cell lines and cell culture
Mousemammary epithelial cell line HC11was routinely maintained
in growthmedia (Haines et al., 2009). Jak2 suppressed HC11 cell popu-
lations were generated by transfecting shRNAs with Lipofectamine™
2000 (Invitrogen) and cells were screened with 1 μg/ml puromycin
(InvivoGen) selection. Jak2 suppressed HC11 cells were rescued with
expression of human Jak2/PCIneo selected in 250 μg/ml G418.
2.3. 3D cell culture
The Poly-D-Lysine coated 8-well culture slides (BD Biosciences) were
utilized for 3D culture. Brieﬂy, each well of the culture slide was ﬁrst
coated with 100 μL growth factor reduced Matrigel® (BD Biosciences),
after polymerization, 5000 cells in 100 μL growth medium were plated
and allow 1.5 h for cells to attach. 100 μL growth media containing 10%
Matrigel® was added on top, creating a ﬁnal concentration of 5%
Matrigel® in full growth medium. Cells were maintained in growth me-
dium with 5% Matrigel® for two days for cell colonies outgrowth. The
morphology of the colonies were evaluated after 3 days of 5 different
treatments: (1) control (CTL): 2% FBS, (2) EGF: EGF 10 ng/ml and 2%
FBS or (3) HIP, 1 μM hydrocortisone, 5 μg/ml insulin, 2 μg/ml ovine PRL
and 2% FBS, (4) HI, 1 μM hydrocortisone, 5 μg/ml insulin and 2% FBS
and (5) PRL, 2 μg/ml ovine PRL and 2% FBS.Mouse primarymammary ep-
ithelial cells were prepared from mid-pregnant C57BL/6 (Jackson Mice)
females inDMEM/F12mediawith 5% FBS using a kit, STEMCELL Technol-
ogies Inc. (Canada). Isolated MECs (5000 cells/well) were plated for 3D
culture.
3. Results
3.1. Prolactin functions as a polarity signal in mammary epithelial cells
The use of 3D culture of mammary organoids, primary mammary
epithelial cells as well as mammary cell lines was instrumental in
deciphering the contributions of hormonal/growth factors, extracellular
matrix proteins and intracellular signaling pathways in mammary epi-
thelial morphogenesis, gland (Lo et al., 2012; Shaw et al., 2004). To
investigate the possible role of PRL in establishing A/B polarity in mam-
mary epithelial cells, we used HC11mouse mammary epithelial cells inFig. 1. PRL induces mammary acini morphogenesis. (A) HC11 and primary mouse mammary ep
ZO1 (green) and E-cad (red). Nucleuswas counter stainedwith DAPI (blue). (B) Percentage of a
mammary epithelial cells. Error bars representmean± s.e.m. of 3 independent experiments. P v
stained with 100 ng/ml Nile Red for 20 min and pseudo-colored in green. Nuclei were counter3D Matrigel culture system. HC11 cells recapitulate many aspects of
mammary luminal epithelial cells. They require EGF for cell proliferation
and undergo differentiation following PRL stimulation (Taverna et al.,
1991; Ball et al., 1988).We found that HC11 cells grown in the presence
of EGF to form large disorganizedmammary colonies that are character-
ized by the lack of lumen and A/B polarization as determined by ZO-1
and E-cad localization. In contrast, colonies treated with the lactogenic
hormone combination of hydrocortisone (H), insulin (I) and PRL (HIP)
formed mammary acini in which the cells are polarized and organized
arounda single lumen resembling the inner lobular core of alveoli in lac-
tating mammary glands (Fig. 1A, left panel). To distinguish the speciﬁc
effector hormone mediating these structural organizations, cells were
grown in the presence of PRL alone, HI or serum (CTL). Interestingly,
only PRL treated cells showed organized mammary acini. In contrast,
no organized acini were observed in HI or serum treated cells (Fig. 1A,
left panel, Fig. S1A). This data together establish the role of PRL as a
mammary epithelial morphogen inducing A/B polarization. To further
validate and extend our ﬁndings that PRL initiates alveolarmorphogen-
esis, we performed similar experiments using primary mammary epi-
thelial cells (MECs) dissociated from mid-pregnant C57BL/6 mice.
Importantly, similar organized alveolar acini were observed only in
cells treated with either a mixture of HIP or PRL alone (Fig. 1A right
panel, Fig. S1B). To enumerate the observed effects of PRL on cellular po-
larization, we quantiﬁed the organized acini within the various treat-
ments. As can be seen in Fig. 1B & C, cells treated with HIP or PRL
showed signiﬁcant increase in the development of organized acini in
comparison to cells treated with EGF, HI or serum. Occasionally, we
also observed the generation of multi-lumen acini in colonies grown
in the presence of EGF (Fig. S1C). Moreover, the size of the colonies
grown in PRL treated cells were the smallest of all (Fig. S1D). This data
highlight PRL as a polarity cue in mammary epithelial cells.
During lactation, directional secretion is an important functional
property of alveolar cells and is determined by the establishment of
A/B polarity. Therefore, we next examined the functionality of these
acini by staining with Nile Red, a ﬂuorescent dye labeling cytoplasmic
lipid droplets (Greenspan et al., 1985). Indeed, formation/accumulation
of lipid droplets is contingent upon alveolar cell secretory differentiation
(Russell et al., 2011). Notably, only HIP treated acini were found to accu-
mulate large granular lipid droplets localized at the apical/luminal side of
the acini (Fig. 1D). No lipid droplets were observed under all other con-
ditions tested. Moreover, no lipid accumulation was observed in EGF
treated colonies showing multilumen acini or structurally normal acini
in HI treated colonies (Fig. 1E). This data together indicate that PRL is re-
quired for lipid droplet apical trafﬁcking/accumulation, signature of alve-
olar cell secretory differentiation.3.2. Prolactin/Jak2 signaling mediates mammary epithelial polarity
establishment and junction organization through regulating Erk1/2 activity
The Jak2 kinase is known to be the major kinase mediating PRL sig-
naling in mammary gland development and lactation (Wagner and Rui,
2008). To determine the downstream signaling mechanism mediating
PRL morphogenic effects, we used multiple short hairpin RNAs
(shRNAs) targeting mouse Jak2 to block PRL signaling. We generated 6
independent stable populations of HC11 cells with Jak2 knockdown.
After screening, two of the stable cell lines J5 and J6 showed Jak2 knock-
down (63.4% and 63.6% suppression, respectively) and were used for
our analyses (Fig. S2A–C). Moreover, we veriﬁed Jak2 knockdown in
J6 cells using qRT-PCR (Fig. S2D). We then generated J6Rh stable cell
line overexpressing human Jak2 cDNA in J6 cells for rescue experimentsithelial cells grown in 3D culture (Materials and Methods) were stained with antibody to
cini/totalmammary colonies (N100 colonies in duplicates) inHC11 cells and (C) in primary
alues derived fromunpaired two-tailed Student's t-test. (D) & (E)MECs in 3D culturewere
stained with DAPI. Scale bar, 10 μm.
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we used Stat5 phosphorylation as readout of PRL/Jak2 signaling. In con-
trast to parental and vector transfected cells, PRL was unable to induce
Stat5 phosphorylation in J5 and J6 cells (Fig. 2A). Whereas PRL induced
Stat5 phosphorylation was restored in J6Rh cells (Fig. 2A). We next ex-
amined the ability of J5 and J6 cells to form acini in 3D culture. Impor-
tantly, both cell lines failed to form organized acini in the presence of
HIP (Fig. S2F) or PRL (data not shown). Of note, J5 and J6 cells grown
in EGF showed striking morphological features. These colonies formed
disorganized spreading cell clumps with diffused ZO-1 and E-cad stain-
ing (Fig. S2F). To get a better understanding of the role of Jak2 in cellular
junction formation, we next examined the localization of cellular junc-
tionmarker proteins ZO-1 and E-cad in 2D culture model. Interestingly,
we found a completemislocalization of ZO-1 and E-cad proteins in both
J6 and J5 cells, showing diffused cytoplasmic staining, while rescuing
Jak2 expression was able to restore membrane localization of both
markers in J6Rh cells (Fig. 2B, Fig. S2G, top panel). These results empha-
size the critical role of Jak2 in cellular junction organization. To further
investigate whether other polarity protein complexes were affected in
J6 cells, we considered the Par protein complex which has previously
been described as part of an evolutionarily conserved complex that
plays an important role in establishing cellular polarity (Goldstein and
Macara, 2007). In polarized cells, the protein Par3 is known to be local-
ized in association with apical junction complexes (Nelson et al., 2013).
Therefore, we next examined the localization of Par3 protein in J5 and J6
cells. We found Par3 to bemislocalized in Jak2 suppressed cells (Fig. 2C,
Fig. S2G bottom panel). Although western blotting results suggested no
differences in expression levels of Par3 as well as other par-complex
proteins including aPKCζ and lgl (Fig. S2H). Importantly, similar to
ZO-1 and E-cad, the membrane localization of this junctional protein
marker Par3 was restored in J6Rh cells (Fig. 2H). Together, this data
highlights Jak2 as a critical mediator of PRL signaling in acinar morpho-
genesis, A/B polarization and junctional organization.
Previous work suggested that PRL/Jak2 signaling exerts inhibitory
effects on Erk1/2 activation (Nouhi et al., 2006; Haines et al., 2009).
We compared the Erk1/2 activation levels between the parental HC11
cells and J6 cells. Interestingly, as can be seen in Fig. 2D, we found
sustained Erk1/2 activation in J6 cells. Indeed, the extent of Erk1/2 activ-
ity was found to be similar to that induced by EGF, a well-known induc-
er of Erk1/2 activation. Similarly, activation of Erk1/2 was also observed
in HC11 cells treated with a Jak2 speciﬁc kinase inhibitor (Jak2I)
(Fig. 2D). We also examined the activation of PI3K/Akt pathway under
these conditions and found no difference in Akt activation in J6 cells in
comparison to HC11 cells (Fig. S2I). Together, these results suggest a
potential role for sustained Erk1/2 activation in disruption of cellular
polarization and junctional organization following loss of Jak2 expres-
sion. To test this hypothesis, J6 cells were treatedwith theMek inhibitor
PD0325901 for a 24 hour time period and cell/cell junction formation
was examined. Notably, treatment of J6 cells with PD0325901 fully re-
stored the membrane localization of ZO-1, E-cad and Par3 (Fig. 2E &
F). Together, this data underscore Jak2 regulation of cellular junctional
organization through modulation of Erk1/2 activities.
3.3. Prolactin promotes the maturation of mammary luminal progenitor
cells
During alveologenesis, alveolar cells also undergo coordinate and irre-
versible phenotypic maturation besides acquiring A/B polarization.
Therefore, we next examined whether PRL plays a role in alveolar cell
fate determination. We hypothesized that PRL regulates MaSC hierarchy
to enrich formature luminal cells. For this reason,we assessed the expres-
sion proﬁle of EpCAM and CD49f using ﬂow cytometry in HC11 cells fol-
lowing stimulation with EGF, HI, HIP or PRL (Fig. 3A). In control EGF
treated cells, we identiﬁed two distinct cellular sub-populations, one fea-
tured a surface marker signature with EpCAMhi/CD49fhi deﬁning the lu-
minal progenitor cells and a second population with EpCAMhi/CD49flowdeﬁning mature luminal cells. Interestingly, treatment of HC11 cells
with HIP or PRL resulted in the differentiation of luminal progenitor
(EpCAMhi/CD49fhi) cells into mature luminal (EpCAMhi/CD49flow) cells
(Fig. 3A). Indeed, we observed a signiﬁcant ~30% of luminal progenitor
cells differentiated into mature luminal cells in these samples (Fig. 3B).
In HI treated cells, on the other hand, we observed no change in pools
of progenitor or mature luminal cells, suggesting that HI plays no role in
the differentiation of luminal cell hierarchy (Fig. 3A&B).Moreover, histo-
gram display of individual markers conﬁrmed the decrease in expression
of CD49f (Fig. 3C, C1) and the increase in expression of EpCAM (Fig. 3C,
C2) in HIP treated cells, in comparison to EGF treated cells. Similar results
were obtained in PRL treated cells in comparison to EGF treated cells
(Fig. 3C, C3 & C4). To further validate the role of PRL in inducing the dif-
ferentiation of mammary luminal progenitor cells into mature luminal
cells we also examined the effects of PRL using primarymousemammary
epithelial cells isolated from mid pregnant mice (Fig. 3D). Importantly,
our data show that treatment of primary cells with either PRL or HIP in-
duced the maturation of progenitor (EpCAMhi/CD49fhi) cells into mature
luminal (EpCAMhi/CD49flow) cells. Altogether, our data reveal a central
role for PRL in promoting the maturation of the mammary luminal
lineage.
We next evaluated the role of Jak2 in promoting the transition of lu-
minal progenitor cells to mature luminal cells. Interestingly, we found
that loss of Jak2 signiﬁcantly abrogated the maturation of luminal pro-
genitor cells tomature luminal cells (Fig. 3E). Indeed, the ratio ofmature
luminal to luminal progenitor cell populationswas found to be higher in
HC11 in comparison to J6 cells most notably at the 48 hour time point
(Fig. 3F). Histogram display of CD49f further showed that there was
sustained expression of CD49f in J6 cells (Fig. 3G) in comparison to
HC11 cells whereas no signiﬁcant change in EpCAM expression was
found in the two different cell lines (Fig. 3H). This data demonstrate
the critical role of Jak2 in mediating PRL-induced luminal maturation
of mammary epithelial cells.
To decipher the mechanism by which PRL/Jak2 mediates mammary
cell luminal maturation we focused on the Erk1/2 pathway as J6 cells
show constitutive Erk1/2 activation. We hypothesized that this in-
creased Erk1/2 activity is impeding J6 cells to undergo luminal matura-
tion. Most importantly, treatment of J6 cells with the Mek1 inhibitor
resulted in the transition of EpCAMhi/CD49fhi to mature EpCAMhi/
CD49flow cells (Fig. 3I). This transition processwas not further enhanced
by the addition of PRL (Fig. 3I). Together, this data indicate that
mammary luminal cell maturation requires tight control of the
Erk1/2 pathway exerted by PRL/Jak2 signaling. Collectively, our
ﬁndings show that PRL coordinates both polarity cues and cell fate
determination for mammary epithelial cells. These newly deﬁned
functions for PRL are of high signiﬁcance in understanding the normal de-
velopment of the mammary gland and its carcinogenesis where these
mechanisms are deregulated.
4. Discussion
Understanding mammary gland biology is of critical signiﬁcance
given the prevalence of breast cancer worldwide. To characterizemech-
anisms involved in regulating mammary morphogenesis, extensive
studies have used ex vivo culture model of mammary epithelial cells
on extracellular matrices in the presence of various hormonal and
growth factors. These original studies showed that mammary epithelial
cells to organize into functional acinar architecture resembling mam-
mary alveoli. Information generated using these cellular model systems
have highlighted the role of the ECM component like laminin (Streuli
et al., 1991, 1995) and integrin (Lee and Streuli, 2014) as important reg-
ulators of mammary acini morphogenesis. Furthermore, Xian et.al has
reported the development of mammary acini using HC11 cells cultured
in Matrigel in the presence of EGF (Xian et al., 2005). However, there
have been no studies examining explicitly the role of PRL hormone in
regulating the various aspects of acinimorphogenesis. Herewe describe
Fig. 2. PRL/Jak2 signaling regulates cellular junction organization through inhibition of Erk1/2 activity. (A)Western blot showing Stat5 phosphorylation in HC11, vector transfected (CTL),
J5, J6 and J6Rh cells following PRL stimulation for 10min. Membranes were reprobed for total Stat5 and β-tubulin. (B) HC11, J6 and J6Rh cells grown in 2D culture were stained for ZO-1
(green) and E-cad (red). (C) HC11, J6 and J6Rh cells grown in 2D culture were stained for Par3 (green) and E-cad (red). Scale bar 10 μm. (D) Western blot analysis using antibody to
phospho-Erk1/2 (Thr202/Tyr204) in HC11 and J6 cells following the indicated treatments. EGF was used at 50 ng/ml for 15 min and Jak2 kinase inhibitor (Jak2I) was used at 20 μM for
an overnight period. Membranes were probed for Erk1/2 and β-tubulin. (E) & (F) HC11 and J6 cells were subjected to 200 nM (L) or 500 nM (H) PD0325901 or DMSO mock treatment
for 24 h before staining for ZO1 (green) and E-cad (red) (E) or Par3 (green) and E-cad (red) (F). Scale bar 10 μm. Merged images show nucleus counter-stained with DAPI (blue).
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larization and luminal cell fate determination.
While there is limited information with respect to physiological li-
gands inducing mammary acini morphogenesis, the literature presents
several growth factors, oncogenes and signaling pathways that areinvolved in disrupting mammary cell polarity and acini formation.
Indeed, it was shown that FGF (Xian et al., 2005); TGFβ (Ozdamar
et al., 2005); Erbb2 (Aranda et al., 2006) and Ephrin B1 (Lee et al.,
2008) as well as NFκB (Becker-Weimann et al., 2013) to interfere
with mammary acini formation/organization. Thus, our results
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morphogenesis is highly signiﬁcant. Indeed, our results demonstrate
a novel regulatory PRL-dependent mechanism coordinating mam-
mary acini organization.
The current view of mammary acini organization and lumen forma-
tion implicate apoptosis in shaping acini lumens (Humphreys et al.,
1996; Debnath et al., 2002; Mailleux et al., 2008). Indeed, studies utiliz-
ing themammary epithelial cell lineMCF10Ahave indicated thatwithin
the mammosphere the inner cell population undergoes anoikis due to
lack of matrix attachment and growth factor exposure resulting in
lumen formation and have implicated the pro-apoptotic protein Bim
in this process. Our results highlight two potentially coordinated mech-
anisms regulating lumen formation. Indeed, while PRL treated acini
show well established polarity we noticed that the lumen of these
colonies are small in comparison to acini grown under HIP treatment
conditions. This data implicate insulin and/or hydrocortisone in apical
membrane generation/expansion. Indeed, studies performed with
MDCK cells do implicate lipid metabolism in apical membrane genera-
tion (Bryant et al., 2010). Therefore, we propose that lipid metabolism
downstream of insulin is potentially leading to the expanded lumen
seen in HIP treated acini.
Notably, our stem cell proﬁling analyses using EpCAM and CD49f
stem cell markers in HC11 and in primary mammary epithelial cells
isolated from mid-pregnant mice showed similar proﬁle, conﬁrming
the luminal origin of HC11 cells. Furthermore, these proﬁles identiﬁed
only two subpopulations comprising the luminal progenitors and
mature luminal cells. No basal or stromal cells could be detected
(EpCAMlow/CD49fhi or EpCAMlow/CD49flow) as has been documented
using primary mammary epithelial cells isolated from virgin mice. To-
gether, these results indicate the enrichment of the luminal linage dur-
ing pregnancy (Visvader and Stingl, 2014; Shehata et al., 2012).
Moreover, using these cellular model systems we show that PRL
through Jak2 plays a critical role as amammary cell fate determinant in-
ducing the differentiation of mammary progenitor cells into mature lu-
minal cells capable of acinar morphogenesis. The role of PRL/Jak2
pathway in regulating mammary luminal maturation is also supported
by the observations that Stat5a/b knockoutmice show loss ofmammary
luminal cell population (Yamaji et al., 2009). Together our results
demonstrate that PRL hormone through Jak2 kinase couples both cellu-
lar A/B polarization and mammary stem cell hierarchy.
The Erk1/2 signaling cascade regulates a variety of cellular processes
by phosphorylating multiple target proteins (Leﬂoch et al., 2009; Yoon
and Seger, 2006). Our results highlighted the negative cross-talk be-
tween PRL/Jak2 and the Erk1/2 pathway to be critical in regulating
both mammary epithelial A/B polarity and stem/progenitor cell differ-
entiation. We have reported previously that this negative cross-talk
was found to be important in PRL's ability to block EGF-induced mam-
mary epithelial cell proliferation as well as in PRL's ability to block
EMT process in breast cancer cells. Although the detailed network of
crosstalk between PRL/Jak2 and Erk1/2 pathway is yet to be established,
it is likely to involvemultiplemechanisms that needs to be further elab-
orated. Interestingly, it was reported that EpCAM expression itself may
regulate cadherin mediated cell adhesion through suppression of the
MAPK signaling cascade (Maghzal et al., 2013). Therefore, it is possible
to postulate that PRL-mediated increase in EpCAM expression observedFig. 3. PRL/Jak2 promotes mammary luminal linage differentiation. (A) Dot plots of representa
(n = 4). (B) Quantiﬁcation of progenitor maturation in HC11 cells following the indicated tre
treatments were normalized to control EGF treated cells. Error bars represent mean ± s.e.m. o
(C) Representative histogram display of CD49f (C1) and EpCAM (C2) expression proﬁle in E
EpCAM and CD49f expression proﬁle in MECs with the indicated treatments. (E) Dot plots of r
for 24 h and 48 h (n = 4). (F) Ratio of mature luminal cells/luminal progenitors (mL/lP) in HC
(n = 3). (G) Representative histogram display of CD49f expression proﬁle in HC11 (left) and J
EpCAM expression proﬁle in HC11 (left) and J6 (right) cells treated with HIP for 24 h and 48
for 24 hwith DMSO (J6/CTL), 1 μMPD0325901 (J6/PD), or 2 μg/ml PRL and 1 μMPD0325901 (J6
derived from unpaired two-tailed Student's t-test.may ultimately lead to suppression of the Erk1/Erk2 pathway in mam-
mary epithelial cells allowing acinar morphogenesis.
Finally the results described here have important implications in
expanding our understanding of the role of PRL in breast tumorigenesis.
The role of PRL in breast tumorigenesis is not fully clariﬁed. There have
been reports indicating a pro-oncogenic role for PRL functioning as a
local autocrine growth factor in mammary cells. Moreover, data gener-
ated from in vivo studies have highlighted PRL to play a permissive role
in oncogene-induced mammary tumorigenesis (Fernandez et al., 2010;
Wennbo et al., 1997; Rose-Hellekant et al., 2003). Indeed as lumen ﬁll-
ing/repopulation of the luminal space is a hallmark of early breast tu-
mors, we expect restoration of PRL/Jak2 signaling in breast tumor cells
to induce cell polarization and promote lumen clearance. On the other
hand it is known that lumen ﬁlling/repopulation of the luminal space
is a hallmark of early breast tumors, therefore, we propose that restora-
tion of PRL/Jak2 signaling in breast tumor cells to induce cell polariza-
tion and promote lumen clearance. Moreover, our ﬁndings that PRL
promotes thematuration of luminal progenitor cells and induces mam-
marymorphogenesis combinedwith our previous study showingPRL as
a suppressor of EMT process in breast cancer cells (Nouhi et al., 2006)
underscore PRL as a potential tumor suppressor and therapeuticmodality
against breast cancer.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.08.001.
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